Sutter Santa Rosa Regional Hospital

Sutter Santa Rosa Regional Hospital Family Medicine Residency Program Announces Incoming Class of 2023

Posted on May 26, 2020 in Affiliates, People, Scroll Images, Sutter Santa Rosa Regional Hospital

SANTA ROSA, Calif. (May 26, 2020) – The Sutter Santa Rosa Regional Hospital (SSRRH) Family Medicine Residency Program today announced its incoming class of 2023. The 12 new residents were selected from among 850 applicants representing the nation’s top medical schools. SSRRH’s three-year program, one of 450 family medicine training programs in the United States, has trained hundreds of family physicians since its inception in 1938.

SSRRH’s Family Medicine Residency is a critical strategic asset with which to combat the emerging physician shortage in Sonoma County. The residency has been the largest single source of family physicians to Sonoma County for over 80 years. Residency graduates comprise nearly half of family physicians in Sonoma County, filling openings in private practices, community clinics, and large medical groups such as Sutter Medical Group of the Redwoods, The Permanente Medical Group, local community health centers, Sonoma County Health Services and leadership positions throughout the medical community.

“One of the amazing things about the specialty of Family Medicine is that we continue to adapt our training in order to provide the services that are needed by the particular community and the time in which we serve. After the last three years filled with fires and a SARS-CoV2 pandemic, it is becoming increasingly clear that we need to train doctors who are flexible and can adapt to, and even lead, in disaster,” says Tara Scott, M.D., program director of the residency.

“The Sutter Family Medicine Residency has fortified its position as a key part of the disaster response in the community and we have recruited an amazing class of soon-to-be Family Physicians from all over the country who are attracted to our brand of community-based training and service, says Dr. Scott. “We are thrilled to welcome these 12 amazing young physicians to the county. We know from experience that many will stay here in our community and provide Primary Care for the residents of Sonoma County for years to come.”

The eleven women and one man who will begin the training program in June came from medical schools across the country including: College of Osteopathic Medicine of the Pacific at Western University of Health Science; Frank H. Netter School of Medicine – Quinnipiac University; Edward Via College of Osteopathic Medicine of the Carolinas; George Washington University School of Medicine and Health Sciences; University of California, Davis; University of Kansas School of Medicine; University of Minnesota Medical School; University of Texas Southwestern Medical School; Virginia Commonwealth University School of Medicine; Warren Alpert Medical School – Brown University. They each come with an impressive background of academic achievement and community service.

(Click here for details about each resident.)

The new residents will graduate the program in 2023; they will begin on June 1, 2020.

The Santa Rosa Family Medicine Residency is under the sponsorship of Sutter Santa Rosa Regional Hospital (SSRRH). To provide a broader base of support for the residency and optimize learning experiences for residents, SSRRH engaged Santa Rosa Community Health Centers and Kaiser Permanente in 2006 and continues its affiliations with partners in the community today.

About the Sutter Health Family Medicine Residency Program

With the initiation of formal training in general practice dating back to 1938, Sutter Santa Rosa Regional Hospital (and formerly Sutter Medical Center of Santa Rosa) has an established tradition of excellent training of family physicians with the strong support of community physicians and specialists. In 1969, the program became affiliated with what has since become the Department of Family and Community Medicine at the University of California, San Francisco (UCSF).

About Sutter Santa Rosa Regional Hospital

Sutter Santa Rosa Regional Hospital, part of the not-for-profit, integrated Sutter Health network, has a long, proud history of providing high quality care in Sonoma County and beyond. Because of an unwavering focus on health and healing the hospital is consistently ranked as one of the top hospitals in the region.

Guy Fieri Serves up Meals and Thank-You’s to Hospital Staff

Posted on May 15, 2020 in Scroll Images, Sutter Santa Rosa Regional Hospital

SANTA ROSA, Calif. – Celebrity chef Guy Fieri’s bright smile and goatee may have been tucked behind a cloth mask while serving meals to medical staff at Sutter Santa Rosa Regional Hospital, but make no mistake, his iconic bleached-out tips, tattooed arms, and jovial attitude were on full display.

For Fieri, a wildly popular Food Network show host and a resident of Sonoma County, giving back to hospital staff boils down to one local supporting fellow locals.

Dubbed the ‘Mayor of Flavortown’, Fieri’s lunchtime menu for staff did not disappoint. Out of his camo-colored Knuckle Sandwich food truck, he served up more than 600 meals to staff, including pulled pork sandwiches, penne pasta, grilled vegetables and hearty green salads.

Due to social distancing, Fieri could not hand off each meal face to face. Rather, unit managers came out to the truck collect the food boxes and t-shirts for their staff. To make it personal, Fieri autographed and wrote ‘good job’ on each box.

Fieri made the meal donation a family affair by including his wife, two sons and Knuckle Sandwich crew.

“This is for all those in there working hard day and night,” said Fieri. “This is for them.”

Fieri continues to use his celebrity for helping during the COVID-19 pandemic. He recently teamed up with the National Restaurant Association to raise more than $23 million for struggling restaurant workers across the country.

Could an Experimental Drug Studied for Ebola Work Against COVID-19?

Posted on Apr 8, 2020 in Affiliates, California Pacific Medical Center, Community Benefit, Expanding Access, Innovation, Quality, Research, Scroll Images, Sutter Medical Center of Santa Rosa, Sutter Santa Rosa Regional Hospital

Not-for-profit Sutter Health Launches Clinical Trials with Gilead Sciences

clinical trials for Covid-19

Sutter Health, together with health systems across Northern California has teamed up with Foster City-based Gilead Sciences on clinical trials for a promising treatment for COVID-19. The COVID-19 vaccine is at least a year away and now scientists across the globe are investigating existing medicines that might work as treatments.

In April 2020, Sutter began participating in two of Gilead Sciences’ Phase 3, randomized clinical trials to evaluate the use of the company’s drug, remdesivir, in adults diagnosed with COVID-19, the disease caused by the novel coronavirus.

The studies test the clinical efficacy and safety of remdesivir in patients with moderate or severe COVID-19, compared with standard-of-care treatment. The U.S. Food and Drug Administration (FDA) reviews results from Phase 3 trials when considering a drug approval.

Promising Treatment
Remdesivir is an antiviral, intravenous drug made by Gilead Sciences. It’s been available as an experimental compound for years, but has not been approved by the FDA for use in clinical treatment.

Jamey Schmidt, Director of Clinical Research at Sutter’s California Pacific Medical Center (CPMC), quickly saw the potential benefit to patients in partnering drug manufacturers (in this case, Gilead Sciences) with Sutter researchers and physicians skilled in clinical trial start-up and ready to help tackle the infectious disease outbreak.

“Sutter research is committed to bring this investigational treatment to Sutter physicians caring for patients infected with the novel coronavirus,” says Schmidt, who collaborated with Greg Tranah, Ph.D., CPMC’s Scientific Director, and Jennifer Ling, M.D., infectious disease specialist at CPMC and principal investigator of the remdesivir clinical trials at CPMC.

CPMC, Sutter Santa Rosa Regional Hospital, Sutter Roseville Medical Center and Sutter Medical Center Sacramento are participating in the clinical trials of remdesivir, and other Sutter sites may enroll to the studies later this month.

“In response to this global health crisis, we’re proud that Sutter is helping lead efforts across Northern California and seeking new tools to combat this novel infection and lessen the virus’s impact,” says Dr. Ling. “Through research at Sutter, new discoveries will help determine the potential of remdesivir to help individual patients with COVID-19.”

Some patients who have been infected by the novel coronavirus and are severely ill may not meet the study criteria for enrollment in the clinical trials of remdesivir. Instead, they may qualify for treatment via Gilead Sciences’ expanded access program (EAP) for remdesivir. The EAP provides alternative access to the investigational drug for severely ill patients with COVID-19 who do not meet the clinical trials study criteria.

First developed in 2009 and used during the Ebola outbreak in 2014, remdesivir is being studied in multiple clinical trials worldwide to see if it is safe and effective against the coronavirus in humans. The drug was previously tested in animals infected by other coronaviruses like SARS and MERS, and is now being tested in humans to determine if it can reduce the intensity and duration of COVID-19.

“Research at Sutter is helping deliver safe, high-quality care to our patients during this unprecedented pandemic,” says Leon Clark, Vice President, Chief Research and Health Equity Officer, Sutter Health. “By bringing innovation to the forefront of how we can best care for Sutter patients who acquire COVID-19, Sutter’s talented researchers are stepping up to the challenge presented by this global health crisis.”

April 29 Update:
Results from a clinical trial of remdesivir, an antiviral manufactured by Gilead Sciences, led by the U.S. National Institutes of Health (NIH) were reported April 29, 2020. The findings suggest that hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients. The trial (known as the Adaptive COVID-19 Treatment Trial, or ACTT), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, was the first clinical trial launched in the United States to evaluate remdesivir as an experimental treatment for COVID-19.

Additionally, Gilead Sciences also shared preliminary results today from the company’s open-label, Phase 3 SIMPLE trial evaluating five- and 10-day dosing durations of remdesivir in hospitalized patients with severe COVID-19. The study results demonstrated that patients receiving a 10-day treatment course of remdesivir achieved similar improvement in clinical status compared with those patients who were administered a five-day treatment course of the drug.

Sutter is not participating in the ACTT treatment trial nor the SIMPLE clinical trial. However, as described in the above article posted on April 8, Sutter is participating in the two Phase 3, randomized, controlled clinical trials that are testing remdesivir. Gilead Sciences has not yet disclosed when results of these clinical trials will be published. Clinical trials at Sutter testing investigational use of remdesivir will close to enrollment May 29, 2020.

May 4 Update:
On May 1, 2020, remdesivir received FDA Emergency Use Authorization for the treatment of COVID-19. The authorization enables the potential use of remdesivir to treat hospitalized patients suffering from severe COVID-19 disease in the U.S., outside of the context of an established clinical trial of the drug. Based on patients’ severity of disease, the authorization allows for five- and 10-day treatment durations.

Learn more about Sutter research and clinical trials.



Colorful Art Delights Hospital Staff

Posted on Apr 1, 2020 in People, Scroll Images, Sutter Santa Rosa Regional Hospital, Uncategorized

Chalk art at Sutter Santa Rosa

SANTA ROSA, Calif. – Chalk it up to neighborly love in the time of coronavirus.

This week, eight Sonoma residents showed their gratitude for frontline workers at Sutter Santa Rosa Regional Hospital, part of Sutter Health’s integrated not-for-profit network of care, by creating colorful messages of hope and support.

It all started when community organizer Sarah Clark had an imaginative idea—chalk messages to line the hospital’s walkways and entrance.

It didn’t take her long to mobilize, just a quick text to friends, and off they marched with buckets of rainbow-colored chalk in hand.

“We wanted to do something to show our appreciation to the staff working so hard to keep our community healthy, and chalk art seemed like the perfect way to brighten up a grim situation,” said Clark.

Nate with a volunteer

These mood-boosting creations were hand drawn by the volunteers in the span of an afternoon. Their heartfelt messages included sayings such as “We <3 You and Are Rooting For You,” “Our Heroes Wear Scrubs,” and “Stronger Together.”

Hospital staff were grateful for the thoughtful gesture.

Nathanael ‘Nate’ Blaustone, RN and cardiac lead for the hospital’s Outpatient Care Unit (OCU) said, “I walked out of work today and seeing this was so special. It’s funny how something so simple can strike such a strong chord. It feels like our whole community is reminding us we aren’t alone. Before I knew it, there were smiles all over the hospital talking about the artwork made for us outside.”

The Sonoma community is no stranger to hard and uncertain times. It’s the touching moments like this chalk art display that demonstrate how its residents open their arms and band together in times of crisis.

Volunteer Rawna Heichel said, “Being able to bring a little cheer to those on the frontlines protecting us all is the least we can do.”

Before heading back inside the hospital, Blaustone shared a note of thanks.

“Thank you for showing your love in so many wonderful colors for us to see each and every day. The love is real.”

Our Heroes Wear Scrubs
Chalk artwork
Volunteers
Volunteers at the hospital entrance

Sutter Santa Rosa Regional Hospital Names New CEO, Dan Peterson

Posted on Feb 2, 2020 in People, Scroll Images, Sutter Santa Rosa Regional Hospital, Uncategorized

SANTA ROSA, Calif. Sutter Health announced today it has selected Dan Peterson as chief executive officer of Sutter Santa Rosa Regional Hospital (SSRRH), effective Feb. 3. Peterson succeeds Mike Purvis who served as CEO since 2009 and is retiring. As CEO, Peterson will manage all administrative and health care activities for the hospital and provide overall leadership and direction for all hospital physicians and staff. Peterson will also lead facility growth and improvement efforts at Sutter Santa Rosa, including a $173 million hospital expansion and renovation slated for completion in 2022.

“Dan is a skilled hospital administrator and the perfect choice to lead Sutter Santa Rosa and move our mission forward,” said Julie Petrini, president and CEO of Hospitals, Sutter Health Bay Area. “We are pleased to welcome Dan and his family back to the Santa Rosa area and look forward to a bright future as we expand the high-quality health care offered in Sonoma County.”

About Dan Peterson

Dan Peterson studied Economics at Brigham Young University in Utah and completed a master’s degree in Health Services Administration at the University of Michigan in Ann Arbor. He started his career as a director for ambulatory services at UCLA Health System in Los Angeles before moving into roles of increasing responsibility. This included the CEO and Administrator role at The Surgery Center of Santa Rosa for nearly five years. Since 2017, he has served as Chief Administrative Officer for Sutter Lakeside Hospital.

Peterson has a track record for excellence in quality, patient experience, and staff engagement. During his time at Lakeside, the hospital achieved top hospital in Sutter Health for Quality performance in both 2018 and 2019, and top hospital in Sutter Health for Patient Experience in 2018. Peterson also oversaw the complete hospital evacuation and repopulation during the Mendocino Complex Fire, among other accomplishments, and is an active participant in professional organizations, including the American College of Healthcare Executives.

“It continues to be a privilege to work in the Sutter Health network alongside the best and brightest physicians, medical and administrative staff in Northern California,” said Peterson. “I am humbled and honored to now lead more than 1,500 men and women at SSRRH who provide exceptional and high-quality care.”

About Sutter Health
Sutter Health is more than 60,000 people strong thanks to its integrated network of physicians, employees and volunteers. Rooted in Sutter Health’s not-for-profit mission, these team members partner to deliver exceptional care that feels personal. From physician offices to hospitals to outpatient care centers and home services, they proudly support the more than 3 million people in their care—nearly 1 percent of the U.S. population, in one of the most diverse and innovative regions in the world. Sutter team members adopt new technologies, make novel discoveries and embrace creative thinking to help patients and communities achieve their best health. From its street nurse program that provides check-ups for homeless people, to telemedicine-aided specialist consultations, to walk-in care clinics, to video visits, the Sutter Health team goes beyond traditional models to make care more convenient and to nurture and empower people throughout their healthcare journey.

For more information about the Sutter Health network visit: sutterhealth.org | facebook.com/sutterhealth | youtube.com/sutterhealth | twitter.com/sutterhealth